Published in Blood Weekly, August 31st, 2000
"Human CD34- hematopoietic stem cells (HSCs) have been identified as potential precursors of CD34+ HSCs by using xenogeneic transplantation systems," stated K. Ando and colleagues, Tokai University, Japan. "However, the properties of CD34+ cells generated from CD34- cells have not been precisely analyzed due to the lack of an in vitro system in which CD34+ cells are continuously produced from CD34- cells.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.